Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes
Abstract Recombinant interferon-α (IFN-α) treatment functionally cures chronic hepatitis B virus (HBV) infection in some individuals and suppresses virus replication in hepatocytes infected in vitro. We studied the antiviral effect of conditioned media (CM) from peripheral blood mononuclear cells (P...
Guardado en:
Autores principales: | Vaclav Janovec, Jan Hodek, Kamila Clarova, Tomas Hofman, Pavel Dostalik, Jiri Fronek, Jaroslav Chlupac, Laurence Chaperot, Sarah Durand, Thomas F. Baumert, Iva Pichova, Barbora Lubyova, Ivan Hirsch, Jan Weber |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d66559148ab3479e9a9a72c1b20bba42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of Cryopreservation on Viability, Phenotype, and Functionality of Porcine PBMC
por: Yanli Li, et al.
Publicado: (2021) -
SERUM LEVEL AND PRODUCTION OF CYTOKINES BY PBMC IN PATIENTS WITH ATOPIC DERMATITIS
por: A. N. Silkov, et al.
Publicado: (2012) -
Differential micro RNA expression in PBMC from multiple sclerosis patients.
por: David Otaegui, et al.
Publicado: (2009) -
RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma
por: Zhiyi Han, et al.
Publicado: (2021) -
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients.
por: Monica Averna, et al.
Publicado: (2013)